Walleye Trading LLC Cogent Biosciences, Inc. Transaction History

Walleye Trading LLC

  • $41.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.69 - $13.34 $145,417 - $200,193
15,007 Added 63.47%
38,652 $376,000
Q2 2023

Aug 14, 2023
SELL
$9.85 - $13.24 $221,398 - $297,595
-22,477 Reduced 48.73%
23,645 $279,000
Q1 2023

May 15, 2023
BUY
$10.04 - $15.5 $203,490 - $314,154
20,268 Added 78.39%
46,122 $497,000
Q4 2022

Feb 14, 2023
BUY
$10.65 - $14.84 $275,345 - $383,673
25,854 New
25,854 $298,000

Others Institutions Holding COGT

# of Institutions
159
Shares Held
114M
Call Options Held
104K
Put Options Held
163K
View Full List

About Cogent Biosciences, Inc.

COGT Quotes by TradingView
  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $717M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email